despite neutral imaging results, adalimumab did improve other key markers of inflammation in the blood including glyca, crp, tnf, and il-6... september 2008  (25). of migraine. more than 4 million of them have at least 15 migraine days each month. even though many drugs prevent and treat these headaches,.